2016 Hematological Malignancies

LD-IF-RT in other B-cell malignancies; results according to histological subtype

100

Progression Free (comparions of subgroups)

75

50

PF (%)

25

0

0

6

12

18

24

30

36

indolent any progression indolent local progression aggressive any progression aggressive local progression

2 2

38

22

13

10

6

3

30

13

6

3

Time since treatment (months) Number of patients at risk

Haas et al, EJC 2005